Carloni, Paolo
 Distribuzione geografica
Continente #
EU - Europa 1.096
NA - Nord America 1.081
AS - Asia 384
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 1
Totale 2.569
Nazione #
US - Stati Uniti d'America 1.051
RU - Federazione Russa 247
IE - Irlanda 210
SE - Svezia 202
CN - Cina 194
IT - Italia 144
UA - Ucraina 98
TR - Turchia 62
SG - Singapore 56
GB - Regno Unito 53
DE - Germania 48
HK - Hong Kong 45
CA - Canada 30
FI - Finlandia 21
BE - Belgio 17
FR - Francia 17
GR - Grecia 8
CH - Svizzera 7
EU - Europa 7
VN - Vietnam 7
LB - Libano 5
NL - Olanda 5
CZ - Repubblica Ceca 4
PL - Polonia 4
RO - Romania 4
UZ - Uzbekistan 4
AT - Austria 3
IN - India 3
ES - Italia 2
JP - Giappone 2
MN - Mongolia 2
BD - Bangladesh 1
HR - Croazia 1
KE - Kenya 1
LU - Lussemburgo 1
MY - Malesia 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 2.569
Città #
Chandler 231
Dublin 210
Ann Arbor 154
Jacksonville 125
Scuola 71
Izmir 62
Nanjing 56
New York 55
Saint Petersburg 53
Ashburn 51
Hong Kong 45
Wilmington 44
Woodbridge 44
Dearborn 39
Moscow 35
Toronto 30
Beijing 24
Boardman 24
Princeton 21
Ogden 18
Brussels 17
Brooklyn 16
Pisa 16
Singapore 15
Kunming 13
Nanchang 12
Hebei 11
Milan 11
Houston 10
Shenyang 9
Tianjin 9
Helsinki 8
Washington 8
Dong Ket 7
Hangzhou 6
Seattle 6
Falls Church 5
Frankfurt Am Main 5
Trieste 5
Bologna 4
Leiden 4
Ningbo 4
Orange 4
Zhengzhou 4
Auburn Hills 3
Jinan 3
Lausanne 3
Los Angeles 3
Palermo 3
Rietberg 3
Shanghai 3
Thessaloniki 3
Timisoara 3
Bari 2
Candelo 2
Dongguan 2
Duncan 2
Florence 2
Fribourg 2
Genova 2
Hefei 2
Jiaxing 2
Krakow 2
Lanzhou 2
Las Vegas 2
Pontedera 2
Pordenone 2
Pozuelo del Rey 2
Redwood City 2
Rome 2
Aachen 1
Athens 1
Berlin 1
Changchun 1
Changsha 1
Council Bluffs 1
Des Moines 1
Dhaka 1
Fairfield 1
Fuzhou 1
Genoa 1
Guangzhou 1
Hanover 1
Hyderabad 1
Indiana 1
Jülich 1
Landsberg 1
Luxembourg 1
Manila 1
Mumbai 1
Mönchengladbach 1
Nairobi 1
Naples 1
North Bergen 1
Norwalk 1
Olomouc 1
Redmond 1
Rende 1
San Jose 1
Santa Clara 1
Totale 1.692
Nome #
Serpin inhibitors for the treatment of prion and prion-like diseases 163
Mesencephalic dopaminergic neurons express a repertoire of olfactory receptors and respond to odorant-like molecules 148
Permeability Coefficients of Lipophilic Compounds Estimated by Computer Simulations 144
Classical and quantum chemical studies of copper phenanthroline complexes binding the DNA 142
Ionic charge transfer effects in water, channels and enzymes 140
Unifying view of mechanical and functional hotspots across class A GPCRs 135
Anthrax Lethal Factor Investigated by Molecular Simulations 134
Parameterization of novel anticancer drugs via a QM/MM force matching procedure and effect of drug-binding on DNA flexibility 130
Role of protein frame and solvent for the redox properties of azurin from Pseudomonas aeruginosa 126
Understanding anticancer Drug-DNA interactions via molecular dynamics simulations 125
Second step of hydrolytic dehalogenation in haloalkane dehalogenase investigated by QM/MM methods 124
The hydrolysis mechanism of the anticancer ruthenium drugs NAMI-A and ICR investigated by DFT-PCM calculations 122
Computational Study of the DNA-Binding Protein Helicobacter pylori NikR: The Role of Ni2+ 120
Huntigton disease: Cooperative hydrogen bonding in polyQ aggregates 120
Huntingtin: Stability and Interaction with Molecular Partner from Computational Biophysics Studies 117
Protonation state and substrate binding to B2 metallo-beta-lactamase CphA from Aeromonas hydrofila 115
Nitrogen fixation by a biologically-inspired catalyst: An ab initio and hybrid qm/mm molecular dynamics study 114
Structural facets of disease-linked human prion protein mutants: A molecular dynamic study 114
Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein chimeras 111
Water and potassium dynamics inside the KcsA K+ channel 99
Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases 94
Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance 24
Erratum: Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases 23
Erratum: Discovery of a class of diketopiperazines as antiprion compounds 22
Totale 2.706
Categoria #
all - tutte 10.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.506


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020363 0 34 69 14 29 31 72 30 23 32 25 4
2020/2021242 32 3 1 27 4 47 25 2 26 27 16 32
2021/2022264 32 24 1 45 35 6 17 18 7 11 24 44
2022/2023573 72 80 54 66 17 121 63 21 58 4 8 9
2023/2024447 15 3 18 9 60 203 22 13 53 13 8 30
2024/2025189 164 25 0 0 0 0 0 0 0 0 0 0
Totale 2.706